DENALI THERAPEUTICS INC (DNLI)

US24823R1059 - Common Stock

19.1  -2.15 (-10.12%)

After market: 19.13 +0.03 (+0.16%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.00330.53M108.50M48.70M335.70M
Operating Expenses
504.60M527.23M449.20M344.40M272.90M
Research and Development
404.46M423.88M358.70M265.40M212.60M
Selling, General, and Administrative Expenses
100.15M103.35M90.50M79.10M60.30M
Operating Income
-504.60M-196.70M-340.70M-295.80M62.70M
Interest Income/Expense
62.60M51.51M14.80M4.60M9.20M
Income Before Taxes
-427.46M-145.19M-326.00M-291.20M72.00M
Income Tax
N/A30.00K0.00-600.00K800.00K
Net Income
-427.49M-145.22M-326.00M-290.60M71.10M
EBITDA
-496.00M-179.97M-330.30M-287.20M71.20M
 
Per Share Data
EPS Diluted Total Ops
-2.76-1.06-2.60-2.390.63
Non GAAP EPS
-2.86-1.08-2.60-2.390.26
 
Statistics
Profit Margin
N/A-43.94%-300.46%-596.71%21.18%
Operating Profit Margin
N/A-59.51%-314.01%-607.39%18.68%

All data in USD

Charts